Beijing biotech firm banks on GM corn in race to be China's Monsanto

As China prepares to open its $120 billion corn market to genetically modified (GM) seed, little-known Dabeinong Biotechnology hopes to reap the benefits of early biotech investments and a law keeping foreign firms on the sidelines.

Related Keywords

United States ,Longping ,Sichuan ,China ,Iowa ,Inner Mongolia ,Nei Mongol ,Henan ,Beijing ,Illinois ,Dabeinong ,Guangdong ,Chinese ,Dominique Patton ,Shen Zhicheng ,Richard Pullin ,Shao Genhuo ,Liu Shi ,Thomson Reuters Trust Principles ,U Corteva Inc ,Dabeinong Technology Group Co ,Reuters ,Citic ,Yuan Longping Agriculture Co Ltd ,Syngenta ,Monsanto ,China Sinochem Holdings ,Dabeinong Biotechnology ,Beijing Dabeinong Technology Group ,China Seed Industry ,Corteva Inc ,Sinochem Holdings ,Ruifeng Biotechnology ,Longping High Tech Agriculture Co Ltd ,Thomson Reuters Trust ,Gmos Dabeinong Pix ,Agricultural Markets ,Animal Feed Trbc Level 5 ,Asia Pacific ,Asia ,Beverages Legacy ,Central Eastern Europe ,Company News ,China Prc ,Commodities Markets ,Corn ,Germany ,East Asia ,Emerging Market Countries ,Europe ,Euro Zone ,Fishing Amp Farming Trbc Level 4 ,Food Amp Drink ,Food Amp Beverages Trbc Level 2 ,Food Processing Legacy ,Food Amp Tobacco Trbc Level 3 ,General News ,Genetically Modified Organisms ,Grains ,Grain Crop Production Trbc Level 5 ,Healthcare Trbc Level 1 ,Consumer Non Cyclicals Trbc Level 1 ,Major News ,Pharmaceuticals Trbc Level 4 ,Pharmaceuticals Trbc Level 3 ,Pharmaceuticals Nec Trbc Level 5 ,Pharmaceuticals Amp Medical Research Trbc Level 2 ,Science Technology ,Western Europe ,